futibatinib

Italy

Drugs containing this active substance

  • LYTGOBI

    It is used for the treatment of adults with bile duct cancer (cholangiocarcinoma) that has spread or cannot be surgically removed, in patients who have already received previous treatment and who present a certain type of abnormal 'FGFR' protein.

    Form: tablets, film-coated

    Active substance Dosage
    futibatinib -

    ATC: L01EN04

    Manufacturer: TAIHO PHARMA NETHERLANDS BV